Mechanism of immunomodulatory drug resistance and novel therapeutic strategies in multiple myeloma
Sign Up to like & getrecommendations! Published in 2022 at "Hematology"
DOI: 10.1080/16078454.2022.2124694
Abstract: ABSTRACT Objective The mechanism of immunomodulatory drugs (IMiDs) resistance to multiple myeloma (MM) cells has been gradually demonstrated by recently studies, and some potential novel strategies have been confirmed to have antimyeloma activity and be… read more here.
Keywords: novel therapeutic; imid resistance; resistance; mechanism ... See more keywords
IMiD Resistance in Multiple Myeloma: Current Understanding of the Underpinning Biology and Clinical Impact.
Sign Up to like & getrecommendations! Published in 2023 at "Blood"
DOI: 10.1182/blood.2023019637
Abstract: Immunomodulatory agents (IMiDs) are a cornerstone of treatment for patients with multiple myeloma. IMiDs are used in therapeutic combinations at all stages of disease and are approved as a single agent maintenance treatment after autologous… read more here.
Keywords: imid resistance; resistance; resistance multiple; multiple myeloma ... See more keywords